Diagnostic power and clinical impact of exome sequencing in a cohort of 500 patients with rare diseases
Caio Robledo D’Angioli Costa Quaio(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Wagner Antonio da Rosa Baratela(Fleury S.A. (Brazil)), Vanessa Galdeno Freitas(Universidade de São Paulo), Sandro Félix Perazzio(Fleury S.A. (Brazil)), Luís Eduardo Coelho Andrade(Fleury S.A. (Brazil)), Gustavo Marquezani Spolador(Fleury S.A. (Brazil)), Alexandre Wagner Silva de Souza(Fleury S.A. (Brazil)), Elisa Napolitano Ferreira(AC Camargo Hospital), Caroline Olivati(Fleury S.A. (Brazil)), Rafaela Rogerio Floriano de Sousa(Fleury S.A. (Brazil)), Viviane Zorzanelli Rocha(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Alexandre Ricardo dos Santos Fornari(Fleury S.A. (Brazil)), Caroline Mônaco Moreira(Fleury S.A. (Brazil)), Rodrigo Fernandes Ramalho(Fleury S.A. (Brazil)), Patricia Rossi Sacramento‐Bobotis(Fleury S.A. (Brazil)), Cintia Reys Furuzawa(Fleury S.A. (Brazil)), Andre Yuji Oku(Fleury S.A. (Brazil)), Matheus Carvalho Bürger(Fleury S.A. (Brazil)), Ana Lígia Buzolin(Fleury S.A. (Brazil)), Aurélio Pimenta Dutra(Fleury S.A. (Brazil)), Gil Monteiro Novo‐Filho(Fleury S.A. (Brazil)), Michele Groenner Penna(Fleury S.A. (Brazil)), Vanessa Dionisio Cantagalli(Fleury S.A. (Brazil)), Miguel Mitne‐Neto(Hospital Santa Paula), Shirley Dezan Matalhana(Fleury S.A. (Brazil)), Fernanda Verzini(Fleury S.A. (Brazil)), Mário Henrique Burlacchini de Carvalho(Aga Khan University Nairobi), Maria Carolina Tostes Pintão(Fleury S.A. (Brazil)), Gustavo Arantes Rosa Maciel(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Vinícius Ceola Pereira(Fleury S.A. (Brazil)), Naiade Romano(Fleury S.A. (Brazil)), Aline dos Santos Borgo Perazzio(Fleury S.A. (Brazil)), Vanessa Yurie Nozaki de Arruda(Fleury S.A. (Brazil)), Maria de Lourdes Chauffaille(Fleury S.A. (Brazil)), Otavio Jose Eulalio Pereira(Fleury S.A. (Brazil)), Chong Ae Kim(AstraZeneca (United States)), Rafael Alves da Silva(Fleury S.A. (Brazil)), David Santos Marco Antônio(Fleury S.A. (Brazil)), Javier Miguelez(Fleury S.A. (Brazil)), Ana Lúcia Pereira Monteiro Catelani(Fleury S.A. (Brazil)), Ana Carolina Gomes Trindade(Fleury S.A. (Brazil)), Monize Nakamoto Provisor Santos(Fleury S.A. (Brazil)), Daniele Paixão(Fleury S.A. (Brazil))
American Journal of Medical Genetics Part C Seminars in Medical Genetics
November 30, 2020
Cited by 39
Related Papers
A Mutation in the Vesicle-Trafficking Protein VAPB Causes Late-Onset Spinal Muscular Atrophy and Amyotrophic Lateral Sclerosis
|The American Journal of Human Genetics|2004|990
International estimated fetal weight standards of the <scp>INTERGROWTH</scp>‐21<sup>st</sup> Project
|Ultrasound in Obstetrics and Gynecology|2017|358
Rare variants in <i>SOS2</i> and <i>LZTR1</i> are associated with Noonan syndrome
|Journal of Medical Genetics|2015|245
International standards for early fetal size and pregnancy dating based on ultrasound measurement of crown–rump length in the first trimester of pregnancy
|Ultrasound in Obstetrics and Gynecology|2014|239